동영상
-
Cancer blood test closer to FDA approval
-
SRK, Ajay Devgn & Tiger Shroff respond to Notices as FDA Moves to next step on Vimal ad row
-
FDA approves breakthrough drug to treat advanced pancreatic cancer
-
“FDA Needs To Act”: Tukaram Mundhe On Healthy Food & Medicine #Shorts
-
After Restaurants FDA Expands Its Crack Down On Hospital Consumables | Tukaram Mundhe Speaks To NDTV
-
‘Will You Stand Up To Trump?’: Dems Turn The Screws On Trump FDA Chief Nominee In Explosive Hearing
-
Gottlieb on how AI is assisting in the development of cancer vaccines
-
‘This Is Outrageous!’: Murray Explodes Over Trump FDA Nominee Dodging Questions In Fiery Hearing
-
FDA endorses new blood test for detecting cancer
-
Gatorade recalls more than 122,000 cases over undeclared food dyes
블로그
- FDA] FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical For Immediate Release August 18, 2026 The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative a
- FDA] FDA Proposes Rule to Modernize Drug Manufacturing Registration For Immediate Release July 10, 2026 The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registrati
- FDA] FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multipl For Immediate Release August 07, 2026 The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical
- FDA] FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and For Immediate Release August 13, 2026 The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, mox
- FDA] FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms For Immediate Release August 05, 2026 The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1
- FDA] FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to and is proposing to revoke the authorized use of Citrus Red No. 2 as a color additive in food.
- FDA] FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Chol For Immediate Release July 17, 2026 The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase sub
- FDA] FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications For Immediate Release June 30, 2026 The U.S. Food and Drug Administration today approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy for impr
- FDA] FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufactur Food and Drug Administration announced the selection of seven companies to participate in the FDA PreCheck The FDA launched the PreCheck Pilot Program on February 1, 2026, in response to Executive Order 14293
- FDA] FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone This action aligns with President Trump’s Great American Recovery Initiative, a federal effort to address
뉴스
-
SK바이오팜, 美서 ‘세노바메이트’ 개발·상업화 경험 공유…글로벌 협력 확대
바이오 전문가들과 협력 확대에 나섰다.SK바이오팜은 지난 10일(현지시간) 미국 뉴저지에서 재미한인제약인협회(KASBP) 뉴저지·뉴욕 지부와 공동으로 ‘From Unmet Need to 임상시험, 규제기관 허가, 상업화에 이르는 주요 과제와 협력 방안을 논의했다.이번 컨퍼런스에서는 SK바이오팜이 독자 개발한 세노바메이트(미국 제품명 엑스코프리)의 미국 식품의약국(FDA
- GC녹십자, RTU 제형 '페라미플루프리믹스주' 출시 제품은 미국 식품의약국(FDA) 승인을 받은 뉴라미니다아제 억제제 계열 원료 '페라미비르'를 기반으로 한 국내 유일의 주사형 치료제다. 핵심 경쟁력은 RTU(Ready-to-Use) 제형 도입이다. 의료진 조제 단계를 생략해 투여 준비 시간을 단축하고, 투약 과정에서 발생할 수 있는 인위적 오류를